Avantor, Inc. (AVTR)
NYSE: AVTR · Real-Time Price · USD
11.85
+0.34 (2.95%)
At close: Nov 25, 2025, 4:00 PM EST
11.85
0.00 (0.00%)
After-hours: Nov 25, 2025, 4:27 PM EST
Avantor Market Cap
Avantor has a market cap or net worth of $8.08 billion as of November 25, 2025. Its market cap has decreased by -48.34% in one year.
Market Cap
8.08B
Enterprise Value
11.65B
1-Year Change
-48.34%
Ranking
Category
Stock Price
$11.85
Market Cap Chart
Since May 17, 2019, Avantor's market cap has increased from $4.93B to $8.08B, an increase of 64.04%. That is a compound annual growth rate of 7.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 24, 2025 | 7.85B | -45.28% |
| Dec 31, 2024 | 14.34B | -7.13% |
| Dec 29, 2023 | 15.44B | 8.60% |
| Dec 30, 2022 | 14.22B | -44.64% |
| Dec 31, 2021 | 25.68B | 57.75% |
| Dec 31, 2020 | 16.28B | 56.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 17, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 958.20B |
| Johnson & Johnson | 496.44B |
| AbbVie | 405.63B |
| UnitedHealth Group | 289.01B |
| AstraZeneca | 283.06B |
| Merck & Co. | 249.20B |
| Novartis AG | 244.50B |
| Abbott Laboratories | 221.17B |